Brazil Developing Triple-Combination Antiretroviral Drug

Armen Hareyan's picture

Antiretroviral Drug

Brazil is in the final stages of testing atriple-combination antiretroviral drug, Orival Silveira, coordinator of thetreatment and assistance unit at the Ministry of Health's National Sexually Transmitted Diseases/AIDSProgram, said Wednesday, Xinhuanet reports. The three drugs used in the treatment-- zidovudine, lamivudine and nevirapine -- are being developed by theBrazil-based Oswaldo Cruz Foundation.

The triple-combination therapy will make it easier for HIV-positive people toadhere to their treatment regimens, Silveira said, adding that studies haveshown that treatment regimens with more than two pills daily are more difficultfor people to follow.

According to the health ministry, about 180,000 people inBrazilare undergoing antiretroviral treatment, which is subsidized fully by thegovernment (Xinhuanet, 12/20).

Reprinted with permission from You can view theentire Kaiser DailyHIV/AIDS Report, search the archives, and sign up for email delivery at . The Kaiser Daily HIV/AIDS Report ispublished for, a free service of The Henry J. Kaiser FamilyFoundation.


Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.